• 1
    Castell DO, Johnston BT. Gastroesophageal reflux disease. Current strategies for patient management. Arch Fam Med 1996; 5: 2217.
  • 2
    Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969; 56: 22330.
  • 3
    Blum AL. Treatment of acid-related disorders with gastric acid inhibitors; the state of the art. Digestion 1990; 47(Suppl. 1): 310.
  • 4
    Klinkenberg-Knoll EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB. Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 14: 34951.
  • 5
    Marks RD, Richter JE, Rizzo J, et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994; 106: 90715.
  • 6
    Bate CM, Green JR, Axon AT, et al. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-esophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic esophagitis. Aliment Pharmacol Ther 1997; 11: 75563.
  • 7
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C. Lansoprazole compared with ranitidine for the treatment of non-erosive gastroesophageal reflux disease. Arch Intern Med 2000; 160: 18039.
  • 8
    Bate CM, Green JR, Axon AT, et al. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis. Aliment Pharmacol Ther 1998; 12: 417.
  • 9
    Hartmann M, Theiss U, Huber R, et al. Twenty-four-hour pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther 1996; 10: 35966.
  • 10
    Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice daily omeprazole or lansoprazole. Aliment Pharmacol Ther 2000; 14: 70914.
  • 11
    Pappa KA, Gooch WM, Buaron K, et al. Low dose ranitidine for the relief of heartburn. Aliment Pharmacol Ther 1999; 13: 45965.
  • 12
    Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115: 13359.
  • 13
    Kromer W, Kruger U, Huber R, Hartmenn M, Steinijans VW. Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. Pharmacology 1998; 56: 5770.
  • 14
    De Graef J, Woussen-Colle MC. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs. Gastroenterology 1986; 91: 3337.
  • 15
    Khoury RM, Katz PO, Castell DO. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther 1999; 13: 12114.
  • 16
    Tutuian R, Katz PO, Castell PO. A PPI is a PPI is a PPI; lessons from prolonged ambulatory pH monitoring. Gastroenterology 2000; 118(Suppl. 2): A17A17(Abstract).
  • 17
    Tutuian R, Katz PO, Castell DO. Ranitidine 75 mg improves control of overnight intragastric pH during omeprazole therapy. Am J Gastroenterol 2000; 95: 24372437.
    Direct Link:
  • 18
    Khoury RM, Katz PO, Hammod R, Castell DO. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther 1999; 13: 6758.